Rani Therapeutics Inc.

RANI | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.79

$0 (+0.08%)

Sep 22, 2026, 11:59 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-29.67M	-56.58M	-33.97M	-63.34M	-8.33M	-16.7M
Depreciation & Amortization	900K	1.03M	822K	548K	497K	589K
Stock-Based Compensation	11.8M	16.03M	19.01M	15.78M	22.6M	n/a
Other Working Capital	9.62M	-827K	-1.55M	346K	-3.97M	111K
Other Non-Cash Items	-8.7M	4.57M	-34.96M	-10K	-43.58M	110K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	6.96M	-544K	-2.14M	509K	-3.43M	1.04M
Operating Cash Flow	-18.71M	-35.5M	-51.24M	-46.52M	-32.25M	-14.96M
Capital Expenditures	-88K	-268K	-1.23M	-1.62M	-506K	-1.2M
Cash Acquisitions	n/a	n/a	n/a	-851K	n/a	n/a
Purchase of Investments	-33.97M	-58.72M	-73.26M	-73.82M	n/a	n/a
Sales Maturities Of Investments	26.75M	77.55M	104.35M	3M	n/a	n/a
Other Investing Acitivies	278K	1.25M	n/a	851K	n/a	n/a
Investing Cash Flow	-7.03M	19.81M	29.86M	-72.44M	-506K	-1.2M
Debt Repayment	-20.72M	-5M	n/a	29.57M	-2.85M	4.19M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-59K	-47K	-162K	-886K	26K	-2.78M
Financial Cash Flow	40.3M	13.59M	233K	29.01M	77.15M	72.68M
Net Cash Flow	14.56M	-2.1M	-21.14M	-89.95M	44.4M	56.52M
Free Cash Flow	-18.8M	-35.76M	-52.47M	-48.13M	-32.75M	-16.16M
Adj. Free Cash Flow	-30.6M	-51.8M	-71.47M	-63.92M	-55.35M	-16.16M
Maintenance CapEx	n/a	n/a	-1.23M	-1.62M	n/a	-1.2M
Growth CapEx	-88K	-268K	n/a	n/a	-506K	n/a
Owner Earnings	-18.71M	-35.5M	-52.47M	-48.13M	-32.25M	-16.16M